X0202 SCHEDULE 13G/A 0001529735 XXXXXXXX LIVE 4 Mandatory Redeemable Preferred Shares 03/31/2026 0001725472 Carlyle Tactical Private Credit Fund 143106B*2 One Vanderbilt Avenue Suite 3400 New York NY 10017 Rule 13d-1(b) MetLife Investment Management, LLC DE 5000000 0 5000000 0 5000000 N 11.9 IA The percent of class is calculated based on 42,000,000 Mandatory Redeemable Preferred Shares (as defined herein) outstanding. Carlyle Tactical Private Credit Fund One Vanderbilt Avenue, Suite 3400, New York, New York, 10017 MetLife Investment Management, LLC (the "Reporting Person") One MetLife Way, Whippany, New Jersey 07981 Delaware N IA The Series F Mandatory Redeemable Preferred Shares, the Series G Mandatory Redeemable Preferred Shares, the Series H Mandatory Redeemable Preferred Shares, the Series J Mandatory Redeemable Preferred Shares, the Series K Mandatory Redeemable Preferred Shares and the Series L Mandatory Redeemable Preferred Shares form a single class of the Issuer's preferred equity securities and are collectively referred to in this Schedule 13G as the "Mandatory Redeemable Preferred Shares." The CUSIP number of the Series F Mandatory Redeemable Preferred Shares is 143106B*2. The CUSIP number of the Series G Mandatory Redeemable Preferred Shares is 143106B@0. The CUSIP number of the Series H Mandatory Redeemable Preferred Shares is 143106B#8. The CUSIP number of the Series J Mandatory Redeemable Preferred Shares is 143106C@9. The CUSIP number of the Series K Mandatory Redeemable Preferred Shares is 143106C#7. The CUSIP number of the Series L Mandatory Redeemable Preferred Shares is 143106D*0. As of March 31, 2026, the Reporting Person may be deemed to be the beneficial owner of 5,000,000 Mandatory Redeemable Preferred Shares, representing approximately 11.9% of the Mandatory Redeemable Preferred Shares outstanding. This percentage is calculated based on 42,000,000 Mandatory Redeemable Preferred Shares outstanding. 11.9% 5,000,000 0 5,000,000 0 Y N The Reporting Person manages these Mandatory Redeemable Preferred Shares on behalf of various clients, including Metropolitan Life Insurance Company. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. MetLife Investment Management, LLC /s/ Israel Grafstein 04/07/2026